Author:
Jakobsen Preben,Steiness Eva,Bastholt Lars,Dalmark Mads,Lorenzen Anders,Petersen Dorthe,Gjedde Susanne B.,Sandberg Erik,Rose Carsten,Nielsen Ole S.,Mouridsen Henning T.,Jakobsen Anders
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference18 articles.
1. Akaike H (1976) An information criterion (AIC). Math Sci 14: 5
2. Ambrosini G, Balli M, Garusi G, Italian Multicentre Breast Study With Epirubicin. (1988) Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. J Clin Oncol 6: 976
3. Benjamin RS, Wiernik PH, Bachur NR (1974) Adriamycin chemotherapy-efficacy, safety and pharmacologic basis of an intermittent single high-dose schedule. Cancer 33: 19
4. Blackstein ME, Eisenhauer E, Wierzbicki R (1987) Phase II study of epirubicin in untreated patients with extensive small cell lung cancer. Proc ECCO 4: A85
5. Camaggi CM, Strocchi E, Martoni A, Angelelli B, Comparsi R, Panutti F (1985) Epirubicin plasma and blood pharmacokinetics after single i.v. bolus in advanced cancer patients. Drugs Exp Clin Res XI: 285
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献